Biogen Inc. vs Black Hawk Acquisition Corporat — Valuation Comparison 2026
Access all valuation models for BIIB vs BKHA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →BIIB scores higher with a 8.4/10 quality rating vs BKHA's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing Biogen Inc. (BIIB) and Black Hawk Acquisition Corporat (BKHA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
BIIB currently trades at $196.00 with a QOC of 8.4/10, while BKHA trades at $11.73 with a QOC of 4.1/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).